Brochure
11 Nov 2023
Ethics Approval - Phase III Efficacy Clinical Trial
PDF 231 kB
Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial
Content provided by our supplier
Chanelle McCoy Health
-
IE -
2020On CPHI since
-
1Certificates
-
1 - 24Employees
Company types
Primary activities
Other Content from Chanelle McCoy Health (1)
-
News UK Food Standards Agency recognises Pureis with first-ever Positive Safety Assessment for CBD
This article takes an in depth look at the regulatory process that CBD products must go through for UK sale as a ‘Novel Foods’ supplement, and why it’s important that consumers choose products that have been given a thumbs up for safety by the Food Standards Agency (FSA).
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance